Clinical research in the older cancer patient

Hematology/Oncology Clinics of North America

Volumn 14, Issue 1, 2000, Pages 283-291

  Muss, Hyman B ^a   Cohen, Harvey J ^b   Lichtman, Stuart M ^c  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; CANCER PATIENT; CLINICAL RESEARCH; GERIATRIC PATIENT; GERIATRICS; HUMAN; MALIGNANT NEOPLASTIC DISEASE; ONCOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 0033950051     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70289-6     Document Type: Article

References (14)

1. A. Bicher G. Sarosy E. Kohn Age does not influence Taxol dose intensity in recurrent carcinoma of the ovary Cancer 71 2 supp 1993 594
2. H.J. Cohen Oncology and Aging W.R. Hazzard J.P. Blass Ettinger W.H. Principles of Geriatric Medicine and Gerontology, ed 4 ed 4 1998 McGraw-Hill New York
3. H.J. Cohen The Oncology Geriatric Education Retreat Cancer 80 1997 1354 1356
4. D. Cunningham S. Pyrhonen R.D. James Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer [see comments] Lancet 352 1998 1413
5. W.R. Hazzard N. Woolard Aging and cancer: Integrating geriatrics into the subspecialties of internal medicine Cancer (special issue) 80 1997 1267 1356
6. S.M. Lichtman G. Rosner M. Egorin Clinical pharmacology of paclitaxel in relation to patient age: CALGB 9762 Proceedings of the Annual Meeting of the American Society of Clinical Oncology 18 1999 732a
7. S.M. Lichtman W. Zaheer D. Gal No increased risk of Taxol toxicity in older patients J Am Geriatr Soc 44 1996 472
8. R. Pazdur R. Zinner M.L. Rothernberg Age as a risk factor in irinotecan treatment of 5-FU-refractory colorectal cancer Proceedings of the Annual Meeting of the Annual Meeting of the American Society of Clinical Oncology 16 1997 260a
9. G.L. Rosner J.B. Hargis D.R. Hollis Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: Results from Cancer and Leukemia Group B Study 8541 J Clin Oncol 14 1996 3000
10. L. Schaaf N. Ichhpurani G. Elfring Influence of age on the pharmacokinetics of irinotecan (CPT-11) and its metabolites, SN-38 and SN-38 glucuronide (SN-38G), in patients with previously treated colorectal cancer Proceedings of the Annual Meeting of the American Society of Clinical Oncology 16 1997 708a
11. D.J. Vaughn S.B. Malkowicz B. Zoltick Paclitaxel plus carboplatin in advanced carcinoma of the urothelium: An active and tolerable outpatient regimen J Clin Oncol 16 1998 255
12. A.P. Venook M.J. Egorin G.L. Rosner Phase I and pharmacokinetic trial of paclitaxel in patients with hepatic dysfunction: Cancer and Leukemia Group B 9264 J Clin Oncol 16 1998 1811
13. R. Yancik Cancer burden in the aged: An epidemiologic and demographic overview Cancer 80 1997 1273
14. R. Yancik Integration of aging and cancer research in geriatric medicine The Journal of Gerontology: Medical Sciences 52A 1997 M329 M332